FIELD: biotechnology, medicine.
SUBSTANCE: invention relates to new recombinant allergens that represent mutants of allergens of the natural origin and comprising at least four mutations. Examples of recombinant allergens are allergens Bet v1 and Ves v1. The primary mutations in recombinant allergen are separated of one another by interval for at least 15 Å and is location is characterized by that at least one circle region of surface of size 800 Å doesn't comprise mutations. Recombinant allergens are used as a pharmaceutical agent as a component of pharmaceutical composition that represents vaccine against allergic response reactions. Invention describes methods for using recombinant allergens in pharmaceutical composition for producing the immune response in subject. Invention represents DNA sequences given in the invention claim that encode recombinant allergens, expressing vector comprising DNA and cell-host for providing the recombinant allergen. Also, invention describes methods for preparing pharmaceutical composition and recombinant mutant allergen. Using recombinant allergen allows decreasing the specific IgE-binding capacity as compared with IgE-binding capacity of the natural allergen. Invention can be used in medicine for preparing vaccine against allergic response reactions.
EFFECT: valuable medicinal properties of allergens.
33 cl, 62 dwg, 10 ex
Title | Year | Author | Number |
---|---|---|---|
HYPOALLERGENIC VARIANTS OF MAL D 1, MAIN MALUS DOMECTICA ALLERGEN | 2012 |
|
RU2624030C2 |
RECOMBINANT POLYPEPTIDE BASED ON BIRCH POLLEN ALLERGEN AND APPLE ALLERGEN AS AN ALLERGY VACCINE | 2020 |
|
RU2761431C1 |
VARIANTS OF GROUP 5 ALLERGENS OF CEREALS WITH REDUCED ALLERGENICITY DUE TO MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2658767C1 |
HYBRID PEPTIDE CARRYING PROTEINS AS VACCINES AGAINST ALLERGY | 2012 |
|
RU2630652C2 |
MODIFICATION OF GROUP 6 POACEAE (BLUEGRASS) ALLERGENS WITH LOW ALLERGENIC CAPACITY DUE TO MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2607373C2 |
VERSIONS OF GROUP OF 5 ALLERGENS OF TRUE GRASSES WITH REDUCED ALLERGENICITY RESULTING FROM MUTAGENESIS OF PROLINE RESIDUES | 2010 |
|
RU2575606C2 |
PhI p 5a DERIVATIVES HAVING DECREASED ALLERGENIC CAPACITY AND RETAINED T-CELLULAR REACTIVITY | 2004 |
|
RU2368620C2 |
VERSION OF GROUP I Poaceae ALLERGEN CHARACTERISED BY LOWER ALLERGENICITY AND MAINTAINED T-CELL RESPONSIVENESS (VERSIONS), CODING DNA MOLECULE AND APPLICATION THEREOF | 2005 |
|
RU2409589C2 |
HOUSE DUST MITE PROTEIN | 2007 |
|
RU2570563C2 |
MODULATION OF ANTIGEN IMMUNOGENICITY BY DELETING EPITOPES RECOGNIZED BY NKT-CELLS | 2011 |
|
RU2598247C2 |
Authors
Dates
2006-10-10—Published
2001-11-16—Filed